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Neuropathic pain often arises from damage to peripheral nerves and is difficult to treat.
Activation of opioid receptors in peripheral sensory neurons is devoid of respiratory
depression, sedation, nausea, and addiction mediated in the brain, and ameliorates
neuropathic pain in animal models. Mechanisms of peripheral opioid analgesia have
therefore gained interest, but the role of G protein-coupled inwardly rectifying potassium
(Kir3) channels, important regulators of neuronal excitability, remains unclear. Whereas
functional Kir3 channels have been detected in dorsal root ganglion (DRG) neurons
in rats, some studies question their contribution to opioid analgesia in inflammatory
pain models in mice. However, neuropathic pain can be diminished by activation of
peripheral opioid receptors in mouse models. Therefore, here we investigated effects of
the selective µ-opioid receptor (MOR) agonist [D-Ala2, N-Me-Phe4, Gly5-ol]-enkephalin
(DAMGO) on potassium conductance in DRG neurons upon a chronic constriction injury
(CCI) of the sciatic nerve in mice. For verification, we also tested human embryonic
kidney (HEK) 293 cells transfected with MOR and Kir3.2. Using patch clamp, we
recorded currents at −80 mV and applied voltage ramps in high extracellular potassium
concentrations, which are a highly sensitive measures of Kir3 channel activity. We found
a significantly higher rate of HEK cells responding with potassium channel blocker
barium-sensitive inward current (233± 51 pA) to DAMGO application in transfected than
in untransfected group, which confirms successful recordings of inward currents through
Kir3.2 channels. Interestingly, DAMGO induced similar inward currents (178 ± 36–
207 ± 56 pA) in 15–20% of recorded DRG neurons from naïve mice and in 4–27%
of DRG neurons from mice exposed to CCI, measured in voltage clamp or voltage ramp
modes. DAMGO-induced currents in naïve and CCI groups were reversed by barium
and a more selective Kir3 channel blocker tertiapin-Q. These data indicate the coupling
of Kir3 channels with MOR in mouse peripheral sensory neuron cell bodies, which was
unchanged after CCI. A comparative analysis of opioid-induced potassium conductance
at the axonal injury site and peripheral terminals of DRG neurons could clarify the role of
Kir3 channel–MOR interactions in peripheral nerve injury and opioid analgesia.
Keywords: neuropathy, DRG neurons, DAMGO, peripheral opioid receptors, potassium channels, GIRK channels,
patch clamp
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INTRODUCTION
In European countries, 12–30% of adults suffer from chronic pain
and many of them experience severe limitations in managing
daily life activities (Breivik et al., 2006). Besides the impairment
of patients’ quality of life, chronic pain is a major economic
challenge for social and health care systems. Neuropathic
pain is defined as pain caused by a lesion or disease of the
somatosensory nervous system (IASP, 2017). Patients experience
reduced thresholds to painful mechanical or thermal stimuli, or
pain sensations elicited by normally innocuous stimuli such as
touch, warm or cool temperatures (Baron et al., 2010). Common
causes of this chronic condition are diabetes, herniated vertebral
discs, cancer, chemotherapy, human immunodeficiency virus or
varicella zoster virus, and injuries to nerves due to accidents or
medical procedures (Jensen and Finnerup, 2014).
The treatment of neuropathic pain is challenging and the
side effects restrict the use of many medications. Among these
are opioids such as morphine and fentanyl, which are the
most powerful analgesics available. However, they also induce
constipation which predominantly results from activation of
intestinal opioid receptors (Imam et al., 2018), as well as
respiratory depression, sedation, dizziness, and nausea mediated
in the central nervous system (CNS) (Li and van den Pol,
2008; Imam et al., 2018). Furthermore, their prolonged use
leads to the development of addiction, which has resulted in a
worldwide opioid epidemic (Volkow et al., 2018). Importantly,
the activation of opioid receptors in peripheral sensory neurons
can provide analgesia without CNS side effects (Stein, 1995;
Kalso et al., 2002). In fact, peripheral opioid receptors mediate a
large proportion of the analgesic effects produced by systemically
administered opioids (Stein and Machelska, 2011; Gaveriaux-
Ruff, 2013; Jagla et al., 2014; Spahn et al., 2017). Numerous
preclinical studies have also shown peripheral opioid analgesia
in models of neuropathic pain in rats (Truong et al., 2003; Kabli
and Cahill, 2007; Obara et al., 2007, 2009; Spahn et al., 2018)
and mice (Kolesnikov et al., 2007; Cayla et al., 2012; Hervera
et al., 2012; Labuz and Machelska, 2013; Labuz et al., 2016).
Furthermore, a clinical trial reported attenuation of neuropathic
pain after peripherally applied morphine in patients (Azad
et al., 2000). Activation of peripheral opioid receptors leads to
the inhibition of voltage-gated calcium and sodium channels,
acid-sensing ion channels, transient receptor potential cation
channel subfamily V member 1 (TRPV1), and subfamily M
member 3 (TRPM3) (Gold and Levine, 1996; Endres-Becker
et al., 2007; Cai et al., 2014; Dembla et al., 2017). A particularly
prominent mechanism underlying peripheral opioid analgesia
is the activation of potassium channels in peripheral sensory
neurons (Ocana et al., 2004). Hence, interactions between opioid
receptors and potassium channels pose a promising basis for
the development of novel therapies with an improved side effect
profile.
Potassium channels play a pivotal role in the regulation
of neuronal excitability and their dysregulation contributes to
neuropathic pain (Prescott et al., 2014; Waxman and Zamponi,
2014). Inwardly rectifying potassium (Kir) channels have gained
particular interest due to their crucial role in maintaining
the resting membrane potential of neurons. Of these channels
the G protein-coupled inwardly rectifying potassium (GIRK
or Kir3) channels form membrane bound signaling complexes
with opioid receptors (Luscher and Slesinger, 2010; Nagi and
Pineyro, 2014). Four Kir3 channel subunits have been identified,
Kir3.1–3.4. To form a functional channel, the subunits assemble
in heterotetramers (Kir3.1, 3.3, 3.4) or both hetero- and homo-
tetramers (Kir3.2). The Kir3.1–3.3 subunits are common in the
CNS (Hibino et al., 2010; Luscher and Slesinger, 2010; Nagi and
Pineyro, 2014). In the peripheral neuron cell bodies in dorsal
root ganglia (DRG), the Kir3 mRNA and protein expression,
and function have been shown in rats and humans (Khodorova
et al., 2003; Gao et al., 2007; Nockemann et al., 2013; Chung
et al., 2014; Gorham et al., 2014; Lyu et al., 2015). In contrast, the
data on Kir3 in the mouse DRG are conflicting. Whereas some
studies detected Kir3 mRNA in DRG (Manteniotis et al., 2013;
Saloman et al., 2016), others did not find Kir3 mRNA or protein
in DRG or cutaneous nerves in wild-type mice (Mitrovic et al.,
2003; Nockemann et al., 2013). The latter study suggested that
the absence of Kir3 in DRG neurons underlie the weak or absent
peripheral mu-opioid receptor (MOR)-mediated analgesia in an
inflammatory pain model in wild-type mice; this analgesia was
established by transgenic expression of Kir3.2 in DRG neurons
(Nockemann et al., 2013). However, in neuropathic pain models,
opioids effectively alleviate mechanical and heat hypersensitivity
via activation of peripheral MOR in wild-type mice (Kolesnikov
et al., 2007; Cayla et al., 2012; Hervera et al., 2012; Labuz and
Machelska, 2013; Labuz et al., 2016). These findings raise the
question whether Kir3 channels functionally couple to MOR in
peripheral sensory neurons in mice following neuropathy.
Therefore, our goal in this study was to investigate
the effects of MOR agonist [D-Ala2, N-Me-Phe4, Gly5-ol]-
enkephalin (DAMGO) on potassium conductance in DRG
neurons upon peripheral nerve injury in mice. We hypothesized
that the nerve lesion results in enhanced MOR-induced
potassium conductance in the corresponding DRG sensory
neuron cell bodies. As a model of neuropathic pain we
used a chronic constriction injury (CCI) of the sciatic
nerve, which resembles human peripheral neuropathy (e.g.,
nerve entrapment or compression) (Bennett and Xie, 1988).
To this end, we examined the effects of DAMGO on
potassium conductance using patch clamp in cultured DRG
neurons from naïve mice and mice exposed to CCI. As a
reference, equivalent experiments were performed in human
embryonic kidney (HEK) 293 cells transfected with MOR and
Kir3.2.
MATERIALS AND METHODS
HEK 293 Cell Culture and Transfection
Human embryonic kidney 293 cells transfected with rat
MOR and mouse Kir3.2 and untransfected HEK 293 cells
(control) (German Collection of Microorganisms and Cell
Cultures, Braunschweig, Germany) were maintained in DMEM
(Sigma-Aldrich, Steinheim, Germany) supplemented with
1% penicillin/streptomycin and 10% fetal bovine serum
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(Biochrom, Berlin, Germany) in 5% CO2 at 37◦C, and were
passaged every 2–3 days. The cells were seeded onto plastic
culture dishes (35 mm) a day prior to transfection. The
transfection mixture consisted of 1 µg pcDNA3.1-MOR
(kindly provided by Prof. Christian Zöllner), 1 µg pFLAG-
Kir3.2 (kindly provided by Dr. Dinah Nockemann), 6 µl
XtremeGene added to 88 µl DMEM without supplements
per culture dish. Untransfected cells were cultured
accordingly.
Animals
Animal experiments were approved by the State animal care
committee (Landesamt für Gesundheit und Soziales, Berlin,
Germany) and followed the guidelines of the International
Association for the Study of Pain (Zimmermann, 1983) and
the ARRIVE guidelines (Kilkenny et al., 2010). Wild-type male
C57BL/6J mice (18–35 g, 6–8 weeks old; Janvier Laboratories,
France) were housed in groups of 2–4 per cage lined with ground
corncob bedding, with free access to standard laboratory rodent
chow and tap water, on a 12 h/12 h (8 am/8 pm) light/dark
cycle. Room temperature was 22 ± 0.5◦C and humidity was
60–65%.
Chronic Constriction Injury
The CCI was induced in deeply isoflurane-anesthetized mice by
exposing the sciatic nerve at the level of the right mid-thigh,
and placing three loose silk ligatures (4-0) around the nerve with
about 1-mm spacing. The ligatures were tied until they elicited a
brief twitch in the respective hind limb. The wound was closed
with silk sutures (Labuz et al., 2009; Labuz and Machelska, 2013).
DRG Tissue Preparation and Neuron
Culture
Dorsal root ganglia were isolated from naïve mice and mice
2 days after CCI. Briefly, mice were killed by an overdose of
isoflurane, the vertebral column was removed, washed in PBS,
placed in ice-cold PBS, and the lumbar (three to five) DRG
innervating sciatic nerve ipsilateral to CCI or from the right side
of naïve mice were dissected. The DRG were collected in ice-cold
serum-free working medium (DMEM/HAM’s F12 supplemented
with 1% penicillin/streptomycin). DRG from one animal were
used for one culture. Further handling of the tissue was
performed under a laminar air flow hood in sterile conditions.
The collected DRG tissue was incubated in 1.25% collagenase
(Sigma-Aldrich) for 50 min at 37◦C in a thermoshaker, washed
with PBS and incubated in 2.5% trypsin (Sigma-Aldrich) for
5 min at 37◦C in a thermoshaker. After digestion, the tissue
was triturated using plastic pipette tips and subsequently filtered
through a 40-µm cell strainer. The filtrate was centrifuged, the
supernatant discarded and the cell pellet resuspended in 300–
1000µl culture medium (DMEM/HAM’s F12 supplemented with
1% penicillin/streptomycin and 10% horse serum), depending
on the required cell density. The cell suspensions (30–100 µl)
were then seeded onto poly-L-lysine coated plastic culture dishes
(35 mm) and placed in an incubator (5% CO2 at 37◦C). An
hour later (to allow the cells to settle down), the cell cultures
were topped up to a total of 2 ml of culture medium and
cultured until patch clamp recordings, as previously described
(Nockemann et al., 2013).
Patch Clamp Experiments
Human embryonic kidney 293 cells were recorded 40–50 h
after plating (untransfected cells) or transfection with MOR
and Kir3.2. DRG neurons (medium diameter of 20–35 µm)
(Stucky and Lewin, 1999) were used 20–30 h after cultivation.
Cell viability was evaluated before first experiment by Trypan
Blue exclusion assay. Recordings were carried out in whole-cell
voltage clamp mode. After washing with PBS, cells were bathed in
low potassium extracellular buffer (5.6 mM KCl, 140 mM NaCl,
2.6 mM CaCl2, 1.2 mM MgCl2, 10 mM HEPES, 2.6 mM glucose;
adjusted to pH 7.4 using NaOH; all from Sigma-Aldrich) and
visualized using a Zeiss Axiovert 200 inverse microscope. Patch
pipettes (resistance 3.5–8 M) were fabricated from Borosilicate
glass capillaries using a Sutter P-97 puller (Sutter Instrument,
Novato, CA, United States) and filled with intracellular buffer
(122 mM KCl, 5 mM NaCl, 1 mM CaCl2, 2 mM MgCl2, 10 mM
HEPES, 11 mM EGTA, 4 mM MgATP, 0.25 mM NaGTP; adjusted
to pH 7.4 using KOH; all from Sigma-Aldrich). Currents were
amplified and recorded using an EPC-10 patch amplifier and
Pulse software (HEKA, Lambrecht, Germany), and were sampled
at a frequency of 100 Hz. Cells were superfused by steady flow
of extracellular buffer at a flow rate of 800–1000 µl/min using
a pressurized application system (Perfusion Pressure Kit VPP-6;
Warner Instruments, Hamden, CT, United States) and a suction
pump. Test compounds, DAMGO (10 µM), BaCl2 (3 mM; both
from Sigma-Aldrich), and tertiapin-Q (100 nM; Alomone Labs,
Jerusalem, Israel) were applied using a perfusion valve control
systems (VC-6; Warner Instruments) to switch between vehicle
buffer and buffers containing the test compounds. All recordings
were performed at room temperature. Fast capacitive currents
(i.e., pipette potential) were canceled before seal formation. After
reaching “giga-seal,” the membrane patch was ruptured to achieve
whole-cell configuration. In DRG neurons, the resting membrane
potential was estimated in current-clamp mode shortly after
gaining whole-cell access and action potentials were recorded in
current-clamp mode using stepwise increasing current injections
of 100 ms from 100 to 600 pA. Only cells showing proper
action potential overshoot were included for further experiments.
Cell capacitance, series and input resistance were monitored by
applying test pulses of 10 mV for 10 ms before each recording.
The currents were recorded in voltage-clamp mode at a constant
holding potential of −80 mV in high potassium buffer (140 mM
KCl, 2.6 mM CaCl2, 1.2 mM MgCl2, 5 mM HEPES; adjusted
to pH 7.4 using KOH) for 120 s in the absence or presence
of DAMGO without or with BaCl2 (Nockemann et al., 2013).
Hyperpolarized state and high concentration of potassium in
extracellular buffer were used to increase the electro-chemical
gradient for potassium to drive it into the cell when Kir3 channels
are opened. To reduce “stress” to the cells, high potassium
buffer was carefully washed in over a period of 2 min and cells
were allowed to stabilize for at least 2 min before recording.
For tertiapin-Q experiments we applied voltage ramps from
a holding potential of −40 mV and measured the induced
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FIGURE 1 | DAMGO (10 µM) induces potassium currents in HEK 293 cells transfected with rat MOR and mouse Kir3.2. (A) Number of DAMGO-responders and
non-responders in untransfected and transfected cells. ∗∗P = 0.0013 (Fisher’s exact test) indicates higher proportion of DAMGO-responders to
DAMGO-non-responders in transfected vs. untransfected cells. The cells were sampled from three untransfected and four transfected cell cultures. (B–E) Exemplary
traces of DAMGO-non-responder (B) and DAMGO-responder (C) in untransfected cells, and of DAMGO-non-responder (D) and DAMGO-responder (E) in
transfected cells. (F) Single cell currents in DAMGO-responders. The data points represent single cell values, and the red horizontal line indicates the mean.
Numbers in brackets indicate the number of cells. (G,H) BaCl2 (3 mM)-mediated reversibility of DAMGO-induced currents in untransfected cells (n = 1) (G) and
transfected cells (n = 10; ∗∗P = 0.002, paired t-test) (H). Only DAMGO-responders are shown. Data points represent DAMGO-induced currents of the same cell
before and after application of BaCl2. Dotted lines represent zero current. In all experiments, the currents were recorded in voltage clamp mode at –80 mV in high
potassium extracellular buffer (140 mM). Cells were defined as responding to DAMGO if the resulting current was larger than three times the noise range.
current at −80 mV, based on previously published protocols
(Gao et al., 2007; Gorham et al., 2014). These experiments
were performed in a 45 mM high potassium extracellular buffer
(45 mM KCl, 100 mM NaCl, 2 mM CaCl2, 1 mM MgCl2, 10 mM
HEPES, 10 mM glucose; adjusted to pH 7.4 using KOH) and an
intracellular solution consisting of 120 mM KCl, 20 mM NaCl,
3 mM MgCl2, 10 mM HEPES, 10 mM glucose, 1 mM EGTA,
3 mM NaATP, 0.3 mM NaGTP (adjusted to pH 7.4 using KOH)
(Gorham et al., 2014). The ramps were applied every 10 s for 200 s
in the absence or presence of DAMGO without or with tertiapin-
Q. The analysis of patch clamp recordings was performed
using Nest-o-Patch v1.2 and Prism v6 software (GraphPad
Software, Inc., La Jolla, CA, United States). Effects of DAMGO
were measured as departure from holding current (in voltage
clamp mode experiments) or baseline currents (in voltage ramp
experiments) while running vehicle buffer. Cells were considered
responding to DAMGO application (DAMGO-responders) if the
resulting current was larger than three times the noise range
from the holding and baseline currents, respectively. Effects of
BaCl2 were measured as departure from holding current while
running DAMGO buffer. Effects of tertiapin-Q were measured
as departure from the mean baseline current while running
DAMGO buffer. Drift of baseline was corrected manually or
using the Nest-o-Patch baseline correction tool when necessary.
Statistical Analyses
Data are shown in raw values as bars representing cell numbers,
representative currents, individual data points representing
single cell currents, or means ± SEM. The number of cells
per group was 13–41; the exact numbers are given in Figures.
Statistical analyses were performed using GraphPad Prism
software (Version 5.02 for Windows; GraphPad Software, Inc.).
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The data were normally distributed as evaluated by Kolmogorov–
Smirnov test. The comparison of DAMGO-induced currents
between HEK 293 cells and DRG neurons was done by one-way
analysis of variance (ANOVA). The comparison of DAMGO-
induced currents between DRG neurons from naïve and CCI
mice was analyzed by unpaired t-test. The reversibility of
DAMGO-induced currents by BaCl2 or tertiapin-Q was assessed
by paired t-test. To compare ratios of DAMGO-responders to
DAMGO-non-responders between naïve and CCI mice as well
as between untransfected and transfected HEK 293 cells, the
Fisher’s exact test was used. The differences were defined as
statistically significant if P < 0.05. The statistical tests and the
degree of significance are specified in the Section “Results” or
figure captions.
RESULTS
DAMGO Induces Potassium Currents in
HEK 293 Cells Transfected With MOR
and Kir3.2
To establish the protocol for patch clamp recordings of inward
potassium currents, we first used HEK 293 cells transfected with
MOR and Kir3.2 and untransfected (control) HEK 293 cells.
Effects of DAMGO (10 µM) were recorded in the whole-cell
voltage clamp mode at constant holding potential of −80 mV
and high potassium extracellular buffer (140 mM). Analysis of
all recorded HEK 293 cells revealed a significantly higher rate
of cells responding with inward current to DAMGO application
(DAMGO-responders) in transfected than in untransfected
group (Figure 1A). In the untransfected group, vast majority
of cells did not respond to DAMGO (92%; 12 of total 13
recorded cells) (Figures 1A,B), and only one cell showed very
small, questionable response to DAMGO (Figures 1A,C) (see
also section “Discussion”). In contrast, most of the cells in the
transfected group showed prompt and reversible (by washout)
inward currents upon DAMGO application (71%; 10 of total
14 recoded cells), whereas four cells (29%) were classified as
DAMGO-non-responders (Figures 1A,D,E). The currents were
similar in all DAMGO-responders, although statistical analysis
could not be performed as there was only one responder among
untransfected cells (Figure 1F). Application of the potassium
channel blocker barium (3 mM BaCl2) reversed DAMGO-
mediated currents in one untransfected cell responding to
DAMGO (Figure 1G) and in all DAMGO-responding transfected
cells (Figure 1H), indicating that inward currents were mediated
by potassium channels. These results clearly show functional
coupling of MOR and Kir3.2 in transfected HEK 293 cells.
DAMGO Induces Potassium Currents in
Mouse DRG Neurons
Conferring the recording conditions established for HEK 293
cells, in the next set of experiments we investigated the effects
of nerve injury on DAMGO (10 µM)-induced potassium
conductance in mouse DRG neurons. In addition, we used
voltage ramp experiments in 45 mM potassium extracellular
buffer to reduce the ionic stress in tertiapin-Q experiments,
since the viability of the neurons dramatically decreased during
tertiapin-Q application in voltage clamp mode in 140 mM
potassium buffer. We analyzed neurons from DRG of naïve
mice and from DRG ipsilateral to the CCI (2 days after CCI).
In previous studies, we have shown that mechanical and heat
hypersensitivities are fully established and can be attenuated by
peripherally applied DAMGO at this time point following CCI in
mice in vivo (Cayla et al., 2012; Labuz and Machelska, 2013; Labuz
et al., 2016). Here we found that the rate of DAMGO-responding
neurons between naïve and CCI mice was not significantly
different (Figures 2A, 3A). Thus, in the voltage clamp mode
experiments (Figure 2A), we recorded 15% DAMGO-responders
(5 of total 33 recorded neurons) from naïve mice and 4%
DAMGO-responders (1 of total 26 recorded neurons) from mice
exposed to CCI. In voltage ramp experiments (Figure 3A),
we recorded 20% DAMGO-responders (8 of total 41 recorded
neurons) from naïve mice and 27% DAMGO-responders (9 of
total 33 recorded neurons) from CCI mice. DAMGO-induced
inward currents were comparable between neurons from naïve
and CCI mice; due to low number of DAMGO-responders in
the voltage clamp mode (Figure 2B), the statistical analysis could
only be performed for the voltage ramp experiments (Figure 3B)
(P = 0.6781, unpaired t-test). Nevertheless, in both experimental
conditions the DAMGO-responding neurons showed prompt
inward currents, which could be reversed by barium (3 mM
BaCl2) (Figures 2C–H) and attenuated by a more selective
Kir3 channel blocker tertiapin-Q (100 nM) (Figures 3C–H).
Additionally, the currents of DAMGO-responding neurons from
naïve mice (Figures 2B, 3B) and CCI mice (Figure 3B) were
comparable to currents of DAMGO-responders in MOR- and
Kir3.2-transfected HEK 293 cells (Figure 1F) (P = 0.8866, one-
way ANOVA).
DISCUSSION
In this study, we found that the MOR-selective agonist DAMGO
induces potassium currents in DRG neurons of both naïve mice
and mice with CCI of the sciatic nerve, which were diminished
by barium and tertiapin-Q indicating the involvement of Kir3
channels. The rate of DAMGO-responding neurons and the
DAMGO-induced inward currents did not change following CCI.
In initial experiments, we determined DAMGO-induced
inward potassium currents using a whole-cell voltage clamp
approach in hyperpolarized untransfected and transfected with
MOR and Kir3.2 HEK 293 cells. Among the untransfected cells,
one cell was classified as DAMGO-responder according to the
criterion that the DAMGO-mediated current is three times larger
than the noise range. However, based on the response kinetics
(slow and not clearly corresponding to DAMGO application, very
small current amplitude; Figure 1C), this cell did not appear
to reliably respond to DAMGO. In contrast, the response of
transfected cells was fast and had distinct and tightly correlated to
DAMGO application onset (Figure 1E), similar to the literature
(Kohno et al., 2005; Kobayashi et al., 2006; Nockemann et al.,
2013; Gorham et al., 2014). Furthermore, substantially higher
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FIGURE 2 | DAMGO (10 µM) induces potassium currents in mouse DRG neurons, assessed in the voltage clamp mode. (A) Number of neurons responding and
non-responding to DAMGO from naïve and CCI mice. The proportion of DAMGO-responding to DAMGO-non-responding neurons from naïve vs. CCI mice did not
differ significantly (P = 0.2148; Fisher’s exact t-test). The neurons were sampled from cultures obtained from DRG of nine naïve mice and eight CCI mice. (B) Single
neuron currents in DAMGO-responders. The data points represent single neuron values, and the red horizontal line indicates the mean. Numbers in brackets indicate
(Continued)
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FIGURE 2 | Continued
the number of neurons. (C–F) Exemplary traces of DRG neurons non-responding (C) and responding (D) to DAMGO from naïve mice, and DRG neurons
non-responding (E) and responding (F) to DAMGO from mice on day 2 following CCI. The DAMGO effects are shown before and during BaCl2 (3 mM) application.
(G,H) BaCl2 (3 mM)-mediated reversibility of DAMGO-induced currents in individual neurons from naïve mice (n = 5 neurons; ∗P = 0.017, paired t-test) (G) and CCI
mice (n = 1 neuron) (H). Only DAMGO-responding neurons are shown. Data points represent DAMGO-induced currents of the same neuron before and after
application of BaCl2. Dotted lines represent zero current. In all experiments, the currents were recorded in voltage clamp mode at –80 mV in high potassium
extracellular buffer (140 mM). Neurons were defined as responding to DAMGO if the resulting current was larger than three times the noise range.
ratio of DAMGO-responders in MOR- and Kir3.2-transfected
compared to untransfected HEK 293 cells, and the reversibility
of DAMGO-induced currents by potassium channel blocker
barium clearly demonstrate successful identification of DAMGO-
induced inward currents and suggest they were mediated by
Kir3.2 channels.
Our finding that DAMGO induced similar currents in DRG
neurons of naïve wild-type mice is somewhat intriguing. Whereas
functional Kir3 channels have been consistently identified in rat
peripheral sensory neurons (Gao et al., 2007; Nockemann et al.,
2013; Chung et al., 2014), only a few studies investigated Kir3
channels in these neurons in mice, and the data are inconsistent.
Nockemann et al. (2013) showed very low amounts of Kir3.1
and Kir3.2 mRNA transcripts and no immunoreactivity of the
corresponding proteins in mouse DRG. Using patch clamp
recordings, the authors reported “negligible” inward currents
upon DAMGO application and concluded on the absence of
Kir3 from mouse DRG neurons. However, the size of DAMGO-
induced currents they measured in naïve wild-type mouse DRG
neurons are substantial (1.8 ± 0.4 nA) (Nockemann et al., 2013)
and in fact, much higher compared to currents recorded under
similar conditions and defined as opioid-mediated responses
in rat DRG and spinal cord neurons, or in Xenopus oocytes
transfected with Kir3 (40–800 pA) in other studies (Kohno et al.,
2005; Kobayashi et al., 2006; Gao et al., 2007). The results in these
latter publications are indeed similar to our recordings in MOR-
and Kir3.2-transfected HEK 293 cells (233 ± 51 pA; Figure 1F),
and DRG neurons from naïve mice (206 ± 55 pA, Figure 2B;
178 ± 36 pA, Figure 3B) and CCI mice (207 ± 56 pA,
Figure 3B). Kanjhan et al. (2005) reported the absence of
hyperpolarization-activated potassium currents characteristic for
Kir3 in DRG neurons of newborn mice and argued that Kir3
expression might occur later in the development of the nervous
system, but did not examine older animals. Mitrovic et al. (2003)
stated a lack of Kir3.2-immunostaining in mouse DRG, but
did not present the corresponding data. In a comprehensive
RNA expression analysis of mouse sensory ganglia, Manteniotis
et al. (2013) reported moderate levels of KCNJ3 mRNA coding
for Kir3.1 in DRG and trigeminal ganglia. This, however, is
insufficient to form a functional channel, since functional Kir3
channels are formed by Kir3.1/Kir3.2 heterotetramers and Kir3.2
homotetramers (Luscher and Slesinger, 2010). Interestingly, a
recent study found mRNAs encoding Kir3.1 and Kir3.2 in
mouse DRG, which would allow formation of functional Kir3
channels (Saloman et al., 2016). Taken together, the current
literature suggests low to moderate Kir3 mRNA expression
(Nockemann et al., 2013; Saloman et al., 2016), which may
result in low protein level difficult to detect by immunostaining
(Mitrovic et al., 2003; Nockemann et al., 2013) and functional
analysis (Nockemann et al., 2013) in mouse DRG neurons. Yet,
we found a moderate number of neurons (15–20%) reliably
responding to DAMGO with inward currents in DRG of naïve
wild-type mice. DAMGO-induced currents in our experiments
were diminished by both a general potassium channel blocker
barium, and by tertiapin-Q, currently considered the most
selective Kir3 channel blocker (Jin and Lu, 1998; Kitamura et al.,
2000). Furthermore, considering the patch clamp conditions
in our experiments such as high potassium concentration in
the extracellular buffer and hyperpolarizing holding potential
or voltage ramp mode, which are highly sensitive measures of
Kir3 channel activity (Kobayashi et al., 2006; Gao et al., 2007;
Nockemann et al., 2013; Gorham et al., 2014), the DAMGO-
mediated potassium currents in mouse DRG neurons in our
experiments likely resulted from the activation of Kir3 channels.
This is also supported by the finding that currents of DAMGO-
responding neurons were comparable to Kir3 currents measured
in our MOR- and Kir3.2-transfected HEK 293 cell experiments,
and in rat neurons and Xenopus oocytes in other studies
(Kohno et al., 2005; Kobayashi et al., 2006; Gao et al., 2007).
Although we have not used MOR antagonist, DAMGO is the
MOR-selective agonist (Labuz and Machelska, 2013), and its
effects in the dose of 10 µM (we used here) were reversible by
opioid receptor antagonist naloxone in patch clamp experiments
(Nockemann et al., 2013), suggesting that DAMGO-induced
potassium currents in our experiments are MOR-mediated.
We have also analyzed DRG neurons from mice following
sciatic nerve CCI, and found one DAMGO-responding neuron
(i.e., 4% of all recorded neurons) in the voltage clamp mode,
and nine DAMGO-responding neurons (i.e., 27% of all
recorded neurons) in the voltage ramp experiments. This was
not significantly different compared to DAMGO-responding
neurons from naïve mice (15% and 20%, respectively). Also the
DAMGO-induced inward currents were comparable between
neurons from naïve and CCI mice (see paragraph above and
Figure 3B). As such functional analysis following CCI has not
been performed previously, several studies examined expression
of Kir3 channels or MOR. Following CCI of the sciatic nerve
in transgenic Kir3.2 mice, the Kir3.2 mRNA in the DRG was
not altered (Nockemann et al., 2013). The MOR mRNA or
protein levels were either decreased (Obara et al., 2009), not
altered (Briscini et al., 2002; Kolesnikov et al., 2007), or elevated
(Truong et al., 2003) following CCI. Regardless of these effects
in the DRG cell bodies, the activation of MOR on DRG neuron
peripheral terminals consistently attenuated CCI-induced
hypersensitivity in vivo and nociceptor excitability ex vivo in mice
(Kolesnikov et al., 2007; Cayla et al., 2012; Hervera et al., 2012;
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FIGURE 3 | DAMGO (10 µM)-induced potassium currents in mouse DRG neurons obtained in the voltage ramp mode. (A) Number of neurons responding and
non-responding to DAMGO from naïve and CCI mice. The proportion of DAMGO-responding to DAMGO-non-responding neurons from naïve vs. CCI mice did not
differ significantly (P = 0.596; Fisher’s exact t-test). The neurons were sampled from cultures obtained from DRG of seven naïve and eight CCI mice. (B) Single
neuron currents in DAMGO-responders. The data points represent single neuron values, and the red horizontal lines indicate the means. Numbers in brackets
indicate the number of neurons. (C–F) Exemplary currents of DRG neurons non-responding (C) and responding (D) to DAMGO from naïve mice, and DRG neurons
non-responding (E) and responding (F) to DAMGO from mice on day 2 following CCI. The DAMGO effects are shown before and during tertiapin-Q (100 nM)
application. (G,H) Tertiapin-Q (100 nM)-mediated attenuation of DAMGO-induced currents in individual neurons from naïve mice (n = 8 neurons; ∗P = 0.0204, paired
t-test) (G) and CCI mice (n = 9 neurons; ∗∗P = 0.0073, paired t-test) (H). Only DAMGO-responding neurons are shown. Data points represent DAMGO-induced
currents of the same neuron before and after application of tertiapin-Q. Dotted lines represent zero current. In all experiments, the currents were obtained by voltage
ramps from a holding potential of –40 mV and measured at –80 mV in high potassium extracellular buffer (45 mM). Neurons were defined as responding to DAMGO
if the resulting current was larger than three times the noise range.
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Schmidt et al., 2012; Labuz and Machelska, 2013; Labuz et al.,
2016). This is in line with the accumulation of Kir3.1, Kir3.2,
and MOR proteins at the site of nerve ligation (Schmidt et al.,
2013; Lyu et al., 2015) and the alleviation of CCI-induced
hypersensitivity by DAMGO applied at the CCI site (Cayla et al.,
2012; Labuz and Machelska, 2013; Labuz et al., 2016). Therefore,
the corresponding electrophysiological recordings from the
injury site, for example using in vitro skin-nerve preparations,
appear appealing, but are technically very challenging.
CONCLUSION AND RELEVANCE
Using electrophysiology, we addressed here for the first time
the effect of MOR agonist DAMGO on potassium currents in
mouse peripheral neurons following CCI of the sciatic nerve.
Our data indicate a coupling of MOR and Kir3 in DRG neurons
in naïve mice and following CCI. The number of responding
neurons and the size of DAMGO-induced potassium currents
were comparable between both groups. Hence, the MOR–
Kir3 interactions in peripheral sensory neurons in attenuation
of neuropathic pain presents a worthwhile target for further
investigations. Particularly, site-specific analysis of opioid-
mediated Kir3 conductance along the peripheral pain pathway,
including injury site at the axon and peripheral terminals, could
elucidate the role of Kir3 and MOR in peripheral neuropathies
and their alleviation.
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